Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist

U-67413B (4-hydroxydipropylaminodihydrophenalene) bound with high affinity to both 5-hydroxytryptamine (HT)1A and D2-dopamine (DA) receptor sites. U-67413B depressed 5-HT and DA cell firing rates and depressed synthesis of both neurotransmitters. The drug depressed mouse body temperatures by an amou...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of pharmacology and experimental therapeutics Vol. 268; no. 3; pp. 1304 - 1310
Main Authors PIERCEY, M. F, TANG, A. H, SMITH, M. W, SZMUSZKOVICZ, J, LAHTI, R. A, VONVOIGTLANDER, P. F, SCHREUR, P. J. K. D, MCCALL, R. B, LUM-RAGAN, J. T, HOFFMANN, W. E, FRANKLIN, S. R, CODE, R. A
Format Journal Article
LanguageEnglish
Published Bethesda, MD American Society for Pharmacology and Experimental Therapeutics 01.03.1994
Subjects
Online AccessGet full text

Cover

Loading…
Abstract U-67413B (4-hydroxydipropylaminodihydrophenalene) bound with high affinity to both 5-hydroxytryptamine (HT)1A and D2-dopamine (DA) receptor sites. U-67413B depressed 5-HT and DA cell firing rates and depressed synthesis of both neurotransmitters. The drug depressed mouse body temperatures by an amount similar to that for buspirone, gepirone and ipsapirone, but less than that for 8-hydroxy-N,N-dipropyl-2-aminotetralin. In rats, it produced the 5-HT1A behavioral syndrome. In contrast to 5-HT1A agonists having DA antagonist effects, U-67413B mildly depressed rather than stimulated firing rates of noradrenaline (NA) neurons in the locus ceruleus by a non-alpha-2 receptor mechanism. In behavioral tests designed to measure anxiolytic activities, U-67413B was a slightly more effective anxiolytic than standard 5-HT1A anxiolytics (buspirone, gepirone and ipsapirone). The data are consistent with the hypothesis that effects of 5-HT1A agonists on NA neuron activity are mediated through effects on dopaminergic mechanisms, and that effects on NA neurons could modulate anxiolytic activities of 5-HT1A agonists.
AbstractList U-67413B (4-hydroxydipropylaminodihydrophenalene) bound with high affinity to both 5-hydroxytryptamine (HT)1A and D2-dopamine (DA) receptor sites. U-67413B depressed 5-HT and DA cell firing rates and depressed synthesis of both neurotransmitters. The drug depressed mouse body temperatures by an amount similar to that for buspirone, gepirone and ipsapirone, but less than that for 8-hydroxy-N,N-dipropyl-2-aminotetralin. In rats, it produced the 5-HT1A behavioral syndrome. In contrast to 5-HT1A agonists having DA antagonist effects, U-67413B mildly depressed rather than stimulated firing rates of noradrenaline (NA) neurons in the locus ceruleus by a non-alpha-2 receptor mechanism. In behavioral tests designed to measure anxiolytic activities, U-67413B was a slightly more effective anxiolytic than standard 5-HT1A anxiolytics (buspirone, gepirone and ipsapirone). The data are consistent with the hypothesis that effects of 5-HT1A agonists on NA neuron activity are mediated through effects on dopaminergic mechanisms, and that effects on NA neurons could modulate anxiolytic activities of 5-HT1A agonists.
U-67413B (4-hydroxydipropylaminodihydrophenalene) bound with high affinity to both 5-hydroxytryptamine (HT)1A and D2-dopamine (DA) receptor sites. U-67413B depressed 5-HT and DA cell firing rates and depressed synthesis of both neurotransmitters. The drug depressed mouse body temperatures by an amount similar to that for buspirone, gepirone and ipsapirone, but less than that for 8-hydroxy-N,N-dipropyl-2-aminotetralin. In rats, it produced the 5-HT1A behavioral syndrome. In contrast to 5-HT1A agonists having DA antagonist effects, U-67413B mildly depressed rather than stimulated firing rates of noradrenaline (NA) neurons in the locus ceruleus by a non-alpha-2 receptor mechanism. In behavioral tests designed to measure anxiolytic activities, U-67413B was a slightly more effective anxiolytic than standard 5-HT1A anxiolytics (buspirone, gepirone and ipsapirone). The data are consistent with the hypothesis that effects of 5-HT1A agonists on NA neuron activity are mediated through effects on dopaminergic mechanisms, and that effects on NA neurons could modulate anxiolytic activities of 5-HT1A agonists.
Author J T Lum-Ragan
R B McCall
P F VonVoigtlander
M F Piercey
P J Schreur
A H Tang
R A Lahti
S R Franklin
W E Hoffmann
R A Code
Author_xml – sequence: 1
  givenname: M. F
  surname: PIERCEY
  fullname: PIERCEY, M. F
  organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States
– sequence: 2
  givenname: A. H
  surname: TANG
  fullname: TANG, A. H
  organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States
– sequence: 3
  givenname: M. W
  surname: SMITH
  fullname: SMITH, M. W
  organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States
– sequence: 4
  givenname: J
  surname: SZMUSZKOVICZ
  fullname: SZMUSZKOVICZ, J
  organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States
– sequence: 5
  givenname: R. A
  surname: LAHTI
  fullname: LAHTI, R. A
  organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States
– sequence: 6
  givenname: P. F
  surname: VONVOIGTLANDER
  fullname: VONVOIGTLANDER, P. F
  organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States
– sequence: 7
  givenname: P. J. K. D
  surname: SCHREUR
  fullname: SCHREUR, P. J. K. D
  organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States
– sequence: 8
  givenname: R. B
  surname: MCCALL
  fullname: MCCALL, R. B
  organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States
– sequence: 9
  givenname: J. T
  surname: LUM-RAGAN
  fullname: LUM-RAGAN, J. T
  organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States
– sequence: 10
  givenname: W. E
  surname: HOFFMANN
  fullname: HOFFMANN, W. E
  organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States
– sequence: 11
  givenname: S. R
  surname: FRANKLIN
  fullname: FRANKLIN, S. R
  organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States
– sequence: 12
  givenname: R. A
  surname: CODE
  fullname: CODE, R. A
  organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3977126$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/7908053$$D View this record in MEDLINE/PubMed
BookMark eNpNkF9LwzAUxYNM5jb9CEIfRJ-KSW6ati_CGP6DgT7oc0iTdI20TU06XL-91RXx6R44v3sP5y7RrHWtOUELklASY4JhhhYYUxpDwpMztAzhA2PCGIc5mqc5znACC3T3WknfSOVqtxsiV0YyauzB6CiJq0F7dxh6P3S9bGxryPpWu-5XRnLnWhv6c3RayjqYi2mu0PvD_dvmKd6-PD5v1tu4IoRBTClIo7AqVUoNA6K5pKDyrOCGEYrLIucaA9UADJu0MIlONDOaZ9m4UwCHFbo-3u28-9yb0IvGBmXqWrbG7YNIOcMMKIzg5QTui8Zo0XnbSD-IqfDoX02-DErWpZetsuEPgzxNCf3Juzlild1VX9Yb0f37k6A8EyAIjJnf-vtt_Q
CODEN JPETAB
ContentType Journal Article
Copyright 1994 INIST-CNRS
Copyright_xml – notice: 1994 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1521-0103
EndPage 1310
ExternalDocumentID 7908053
3977126
268_3_1304
Genre Journal Article
GroupedDBID -
08R
0R
2WC
3O-
4.4
53G
55
5GY
5RE
8RP
AALRV
ABFLS
ABIVO
ABOCM
ABSGY
ABZEH
ACGFS
ACNCT
ADBIT
ADCOW
ADKFC
AENEX
AETEA
AFFNX
AIKQT
ALMA_UNASSIGNED_HOLDINGS
CS3
DIK
DL
DU5
EBS
EJD
F5P
FH7
GJ
GX1
H13
HZ
INIJC
KQ8
L7B
LSO
O9-
OK1
P2P
R.V
R0Z
RHF
RHI
RPT
VH1
W2D
WH7
WOQ
X
X7M
ZGI
ZXP
---
-~X
.55
.GJ
0R~
18M
5VS
8WZ
A6W
AAJMC
AAYOK
ABCQX
ABJNI
ABSQV
ACGFO
ADBBV
ADIYS
AERNN
AFHIN
AFOSN
AGFXO
AI.
BAWUL
BTFSW
E3Z
F9R
HZ~
IQODW
MJL
MVM
OHT
TR2
UQL
W8F
YBU
YHG
YQT
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-h1143-223aec0cfc72e431d6a23c98b6e4120fb96d032d3340e7be5d5d4ed6880cfb363
ISSN 0022-3565
IngestDate Fri Oct 25 10:13:40 EDT 2024
Sat Sep 28 07:32:46 EDT 2024
Thu Sep 12 02:08:28 EDT 2024
Tue Jan 05 21:17:27 EST 2021
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Rat
Psychotropic
Rodentia
Discharge pattern
Electrophysiology
Serotonin agonist
In vitro
Biological activity
In vivo
Vertebrata
Mammalia
D2 Dopamine receptor
Tranquillizer
Mouse
Animal
Dopamine agonist
S1A receptor
Behavior
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-h1143-223aec0cfc72e431d6a23c98b6e4120fb96d032d3340e7be5d5d4ed6880cfb363
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 7908053
PQID 76404323
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_76404323
pubmed_primary_7908053
pascalfrancis_primary_3977126
highwire_pharmacology_268_3_1304
ProviderPackageCode RHF
RHI
PublicationCentury 1900
PublicationDate 1994-Mar
PublicationDateYYYYMMDD 1994-03-01
PublicationDate_xml – month: 03
  year: 1994
  text: 1994-Mar
PublicationDecade 1990
PublicationPlace Bethesda, MD
PublicationPlace_xml – name: Bethesda, MD
– name: United States
PublicationTitle The Journal of pharmacology and experimental therapeutics
PublicationTitleAlternate J Pharmacol Exp Ther
PublicationYear 1994
Publisher American Society for Pharmacology and Experimental Therapeutics
Publisher_xml – name: American Society for Pharmacology and Experimental Therapeutics
SSID ssj0014463
Score 1.4812392
Snippet U-67413B (4-hydroxydipropylaminodihydrophenalene) bound with high affinity to both 5-hydroxytryptamine (HT)1A and D2-dopamine (DA) receptor sites. U-67413B...
U-67413B (4-hydroxydipropylaminodihydrophenalene) bound with high affinity to both 5-hydroxytryptamine (HT)1A and D2-dopamine (DA) receptor sites. U-67413B...
SourceID proquest
pubmed
pascalfrancis
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 1304
SubjectTerms Animals
Behavior, Animal - drug effects
Biological and medical sciences
Diazepam - pharmacology
Dopamine Agents - pharmacology
Male
Medical sciences
Mice
Molecular Structure
Neurons - drug effects
Neurons - metabolism
Neuropharmacology
Pharmacology. Drug treatments
Phenalenes
Polycyclic Compounds - pharmacology
Psycholeptics: tranquillizer, neuroleptic
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Rats
Rats, Sprague-Dawley
Receptors, Dopamine D2 - drug effects
Serotonin Receptor Agonists - pharmacology
Title Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist
URI http://jpet.aspetjournals.org/content/268/3/1304.abstract
https://www.ncbi.nlm.nih.gov/pubmed/7908053
https://search.proquest.com/docview/76404323
Volume 268
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdpYdCX0XUry7puehh9cd3ZkizbL4Mw2oaxjTykJW9GsqUmsNihdWDZX7M_dSd_KqFjHy_GFtgn7ne-D-nuhNA7KWKmRCTdIKDCZVorF2AOXMVYTEQYg9Ksun1-5eMb9mkWzAaDn1bW0rqUF-mPR-tK_gdVGANcTZXsPyDbfRQG4B7whSsgDNe_wnjS953e1IWOy8V38CADd77JTH5Keb9ZlWIJnqQ_AjIZRMjmwRF3Rd4U_rSeaV8jVnmnK_vTZnF96ygAq2qr88m_OFfOZGHyZLpV-pEzdqaisY1mVwfU0GcxLxedQoZ3bov8tljcld-qOpt-FaJuJ0y3Mjra7SU713SyO9NLe6bT3Zna1QX1-REXqlHKxCx5eNTW2oRHlnhSSweDVWa2cQDMVstKAkD0Iq_uTbzdeXvHInZ5ikAkoWbHj-2hPeqblNHrWZdCZEJp2nWjhzkfoCcNCavdtMm2FQ_ww-n6pJTfhzKVSzM9RE8btPGoFqxnaKDyI3TW8HNzjm3eneMzbHP6OfpgP-JCY4Er6cOPSt_7VvZwI3sv0M3V5fTj2G1O43DnEDNTF_xIoVIv1WlIFLidGReEpnEkuWI-8bSMeeZRklHKPBVKFWRBxlTGwUCkWlJOj9F-XuTqJcI0VLHmmpheTUz7UkTC5wQcad-LBBF0iHDLvcQW96THY4hOt7iarOrmLIkJaHzCh-hty-UEFKbZBRO5KtYPSchNQykCRI5r5nevNti9-jP1E3TQ_wSv0X55v1an4JyW8k0lIb8ABY2YGg
link.rule.ids 315,782,786
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacology+of+a+mixed+5-hydroxytryptamine1A%2Fdopamine+agonist&rft.jtitle=The+Journal+of+pharmacology+and+experimental+therapeutics&rft.au=M+F+Piercey&rft.au=A+H+Tang&rft.au=R+A+Lahti&rft.au=P+F+VonVoigtlander&rft.date=1994-03-01&rft.pub=American+Society+for+Pharmacology+and+Experimental+Therapeutics&rft.issn=0022-3565&rft.eissn=1521-0103&rft.volume=268&rft.issue=3&rft.spage=1304&rft_id=info%3Apmid%2F7908053&rft.externalDBID=n%2Fa&rft.externalDocID=268_3_1304
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3565&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3565&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3565&client=summon